Schneider Eugene
SEC CIK 1838539 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| IONS | IONIS PHARMACEUTICALS INC | EVP, Chf Clinical Develop Offc | 103.1K | — | $8.05M | 33 | 2021-10-15 | 2026-06-26 |
Most active insiders at IONS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Monia Brett P | CEO, Dir | — | $30.35M |
| 2 | HOUGEN ELIZABETH L | EVP, CFO, Fin | — | $21.12M |
| 3 | BENNETT C FRANK | EVP, CSO | — | $16.71M |
| 4 | Geary Richard S | EVP, Chief Development Off | — | $13.35M |
| 5 | O'NEIL PATRICK R. | GC, EVP CLO | — | $9.17M |
| 6 | Devers Shannon L. | EVP, Chief Human Resources Ofc | — | $8.66M |
| 7 | Swayze Eric | EVP Research | — | $7.51M |
| 8 | LOSCALZO JOSEPH | Dir | — | $7.09M |
| 9 | KLEIN JOSEPH III | Dir | — | $6.00M |
| 10 | WENDER JOSEPH H | Dir | — | $5.44M |
| 13 | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | — | $3.74M |
Transactions 33
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-06-30 17:48 | 2026-06-26 | IONS | IONIS PHARMACEUTICALS INC | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | M - OptEx | $60.89 | +26.0K | 103.1K | +34% | +$1.58M |
| DT | 2026-06-30 17:48 | 2026-06-26 | IONS | IONIS PHARMACEUTICALS INC | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | S - Sale+OE | $81.05 | -26.0K | 77.1K | -25% | -$2.11M |
| 2026-03-23 | 2026-03-19 | IONS | IONIS PHARMACEUTICALS INC | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | S - Sale | $70.97 | -5,812 | 63.9K | -8% | -$412.5K | |
| 2026-02-02 | 2026-01-29 | IONS | IONIS PHARMACEUTICALS INC | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | A - Grant | $0.00 | +12.0K | 75.9K | +19% | $0 | |
| 2026-02-02 | 2026-01-30 | IONS | IONIS PHARMACEUTICALS INC | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | S - Sale | $83.45 | -6,179 | 69.7K | -8% | -$515.6K | |
| D | 2026-01-20 | 2026-01-15 | IONS | IONIS PHARMACEUTICALS INC | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | M - OptEx | $0.00 | +21.7K | 73.2K | +42% | $0 |
| D | 2026-01-20 | 2026-01-16 | IONS | IONIS PHARMACEUTICALS INC | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | S - Sale+OE | $75.59 | -9,302 | 63.9K | -13% | -$703.1K |
| DM | 2025-09-04 | 2025-09-03 | IONS | IONIS PHARMACEUTICALS INC | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | S - Sale+OE | $60.81 | -19.7K | 51.5K | -28% | -$1.20M |
| D | 2025-09-04 | 2025-09-03 | IONS | IONIS PHARMACEUTICALS INC | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | M - OptEx | $53.77 | +19.7K | 71.2K | +38% | +$1.06M |
| 2025-08-05 | 2025-08-04 | IONS | IONIS PHARMACEUTICALS INC | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | S - Sale | $42.80 | -9,549 | 51.5K | -16% | -$408.7K | |
| 2025-02-03 | 2025-01-31 | IONS | IONIS PHARMACEUTICALS INC | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | S - Sale | $32.20 | -1,484 | 61.1K | -2% | -$47.8K | |
| 2025-02-03 | 2025-01-30 | IONS | IONIS PHARMACEUTICALS INC | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | A - Grant | $0.00 | +4,032 | 62.5K | +7% | $0 | |
| D | 2025-01-17 | 2025-01-15 | IONS | IONIS PHARMACEUTICALS INC | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | M - OptEx | $0.00 | +17.4K | 65.0K | +36% | $0 |
| D | 2025-01-17 | 2025-01-16 | IONS | IONIS PHARMACEUTICALS INC | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | S - Sale+OE | $32.79 | -6,523 | 58.5K | -10% | -$213.9K |
| A | 2024-09-04 | 2024-02-02 | IONS | IONIS PHARMACEUTICALS INC | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | S - Sale | $49.59 | -2,106 | 47.7K | -4% | -$104.4K |
| 2024-02-02 | 2024-02-01 | IONS | IONIS PHARMACEUTICALS INC | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | A - Grant | $0.00 | +4,033 | 51.9K | +8% | $0 | |
| 2024-02-02 | 2024-02-02 | IONS | IONIS PHARMACEUTICALS INC | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | S - Sale | $49.59 | -2,071 | 49.8K | -4% | -$102.7K | |
| D | 2024-01-18 | 2024-01-17 | IONS | IONIS PHARMACEUTICALS INC | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | S - Sale+OE | $50.42 | -5,482 | 47.9K | -10% | -$276.4K |
| D | 2024-01-18 | 2024-01-16 | IONS | IONIS PHARMACEUTICALS INC | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | M - OptEx | $0.00 | +15.2K | 53.3K | +40% | $0 |
| D | 2024-01-17 | 2024-01-12 | IONS | IONIS PHARMACEUTICALS INC | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | M - OptEx | $32.60 | +8,000 | 46.2K | +21% | +$260.8K |
| D | 2024-01-17 | 2024-01-12 | IONS | IONIS PHARMACEUTICALS INC | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | S - Sale+OE | $53.50 | -8,000 | 38.2K | -17% | -$428.0K |
| D | 2023-12-28 | 2023-12-26 | IONS | IONIS PHARMACEUTICALS INC | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | M - OptEx | $47.34 | +25.0K | 61.1K | +69% | +$1.18M |
| D | 2023-12-28 | 2023-12-26 | IONS | IONIS PHARMACEUTICALS INC | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | S - Sale+OE | $51.46 | -25.0K | 36.1K | -41% | -$1.29M |
| 2023-02-07 | 2023-02-06 | IONS | IONIS PHARMACEUTICALS INC | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | S - Sale | $40.67 | -1,413 | 24.9K | -5% | -$57.5K | |
| 2023-02-07 | 2023-02-03 | IONS | IONIS PHARMACEUTICALS INC | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | A - Grant | $0.00 | +4,033 | 26.4K | +18% | $0 | |
| D | 2023-01-19 | 2023-01-17 | IONS | IONIS PHARMACEUTICALS INC | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | M - OptEx | $0.00 | +13.0K | 27.1K | +93% | $0 |
| D | 2023-01-19 | 2023-01-18 | IONS | IONIS PHARMACEUTICALS INC | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | S - Sale+OE | $39.57 | -4,752 | 22.3K | -18% | -$188.0K |
| D | 2022-10-18 | 2022-10-17 | IONS | IONIS PHARMACEUTICALS INC | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | M - OptEx | $0.00 | +416 | 14.2K | +3% | $0 |
| D | 2022-10-18 | 2022-10-17 | IONS | IONIS PHARMACEUTICALS INC | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | F - Tax | $46.52 | -144 | 14.0K | -1% | -$6,699 |
| D | 2022-01-20 | 2022-01-18 | IONS | IONIS PHARMACEUTICALS INC | Schneider Eugene | EVP, Chf Clinical Develop Offc | M - OptEx | $0.00 | +10.4K | 17.6K | +145% | $0 |
| D | 2022-01-20 | 2022-01-18 | IONS | IONIS PHARMACEUTICALS INC | Schneider Eugene | EVP, Chf Clinical Develop Offc | F - Tax | $30.12 | -3,815 | 13.8K | -22% | -$114.9K |
| D | 2021-10-19 | 2021-10-15 | IONS | IONIS PHARMACEUTICALS INC | Schneider Eugene | EVP, Chf Clinical Develop Offc | F - Tax | $35.10 | -145 | 7,175 | -2% | -$5,090 |
| D | 2021-10-19 | 2021-10-15 | IONS | IONIS PHARMACEUTICALS INC | Schneider Eugene | EVP, Chf Clinical Develop Offc | M - OptEx | $0.00 | +417 | 7,320 | +6% | $0 |
Purchase Sale Sale after option exercise All abbreviations